WHO ICTRP trial
TO Study The Effect Between Two drug Hyperbaric Ropivacaine 0.75% and Hyperbaric…
CTRI/2023/10/059168 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/10/059168 |
|---|---|
| Public title | TO Study The Effect Between Two drug Hyperbaric Ropivacaine 0.75% and Hyperbaric Levobupivacaine 0.5% in patient with lower limb Orthopedic Surgeries in Spinal Anasthesia. |
| Scientific title | A Comparative Study Between Hyperbaric Ropivacaine 0.75% And Hyperbaric Levobupivacaine 0.5% For Elective Lower Limb Orthopedic Surgeries Under Spinal Anasthesia - NIL |
| Primary sponsor | Uttar pradesh University of medical sciences |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified Health Condition 2: O- Medical and Surgical |
| Interventions | Intervention1: nil: nil Control Intervention1: HYPERBARIC ROPIVACAINE 0.75% AND HYPERBARIC LEVOBUPIVACAINE 0.5% FOR ELECTIVE LOWER LIMB ORTHOPEDIC SURGERIES UNDER SPINAL ANAESTHESIA: A COMPARATIVE STUDY BETWEEN HYPERBARIC ROPIVACAINE 0.75%… |
| Registration date | Oct 26, 2023 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: